Recombinant Proteins Market Size Share Analysis Report 2023-2030 - Benzinga
GNNSF Stock | USD 1.37 0.01 0.72% |
Roughly 61% of Genscript Biotech's investor base is looking to short. The analysis of overall sentiment of trading Genscript Biotech pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Genscript Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Genscript Biotech stock news signals to limit their universe of possible portfolio assets.
Genscript Biotech pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Genscript daily returns and investor perception about the current price of Genscript Biotech as well as its diversification or hedging effects on your existing portfolios.
Genscript |
Recombinant Proteins Market Size Share Analysis Report 2023-2030 Benzinga
Read at news.google.com
Genscript Biotech Fundamental Analysis
We analyze Genscript Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genscript Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genscript Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Z Score
Z Score Comparative Analysis
Genscript Biotech is currently under evaluation in z score category among its peers. Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Genscript Biotech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genscript Biotech pink sheet to make a market-neutral strategy. Peer analysis of Genscript Biotech could also be used in its relative valuation, which is a method of valuing Genscript Biotech by comparing valuation metrics with similar companies.
Peers
Genscript Biotech Related Equities
ONTTF | Oxford Nanopore | 16.88 | ||||
LCTX | Lineage Cell | 7.02 | ||||
INBX | Inhibrx | 3.97 | ||||
TLPPF | Telix Pharmaceuticals | 3.56 | ||||
NUVB | Nuvation Bio | 3.21 | ||||
KROS | Keros Therapeutics | 1.43 | ||||
CRNX | Crinetics Pharmaceuticals | 1.21 | ||||
CVKD | Cadrenal Therapeutics, | 1.11 | ||||
LYEL | Lyell Immunopharma | 1.10 | ||||
MRUS | Merus BV | 1.06 | ||||
NUVL | Nuvalent | 0.71 | ||||
ZNTL | Zentalis Pharmaceuticals | 0.57 | ||||
OVID | Ovid Therapeutics | 0.91 | ||||
CNTB | Connect Biopharma | 1.02 | ||||
ICCC | ImmuCell | 1.07 | ||||
KRON | Kronos Bio | 2.25 | ||||
NXTC | NextCure | 2.50 | ||||
IVBXF | Innovent Biologics | 4.72 |
Complementary Tools for Genscript Pink Sheet analysis
When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Money Managers Screen money managers from public funds and ETFs managed around the world |